Pier Capital »

Denali Therapeutics shares owned by Pier Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Pier Capital from 13F filings

Historical chart of Pier Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Pier Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Pier Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 174k 21.46
2023-09-30 $2.6M 125k 20.63
2023-06-30 $3.8M 127k 29.51